Burghi, Gaston
Biard, Lucie
Roux, Antoine
Valade, Sandrine
Robert-Gangneux, Florence
Hamane, Samia
Maubon, Daniéle
Debourgogne, Anne
Le Gal, Soléne
Dalle, Fréderic
Leterrier, Marion
Toubas, Dominique
Pomares, Christelle
Bellanger, Anne Pauline
Bonhomme, Julie
Berry, Antoine
Iriart, Xavier
Durand-Joly, Isabelle
Magne, Denis
Pons, Denis
Hennequin, Christophe
Maury, Eric
Azoulay, Elie
Lemiale, Virginie
Article History
Received: 22 September 2020
Accepted: 28 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: The appropriate ethics committee approved the first study.
: Non-applicable
: Non-applicable
: It was not required because of observational study.
: Antoine Roux, MD,; Sandrine Valade, MD; Florence Gangneux-Robert, PharmD, PhD; Samia Hamane, MD; Daniele Maubon, MD, PhD; Anne Debourgogne, PhD, MPH; Solène Le Gal, DVM, PhD; Frederic Dalle, PharmD, PhD; Marion Leterrier, PharmD; Dominique Toubas, MD, PhD; Christelle Pomares, MD, PhD; Anne Pauline Bellanger, PharmD, PhD; Julie Bonhomme, MD, PhD; Xavier Iriart, PhD; Isabelle Durand-Joly, PhD; Denis Magne, PhD; Denis Pons, Pharmacien Biologiste; and Eric Maury, MD, PhD, have disclosed no relevant financial relationships. Christophe Hennequin, MD, PhD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Gilead Sciences, Inc., Merck Sharp & Dohme Corp; Pfizer Inc. Elie Azoulay, MD, PhD, has disclosed the following relevant financial relationships: Gilead Sciences, Pfizer, Astellas, Alexion, Fisher-Paykel. Dr. Lemiale has disclosed being memeber of a research group which received grant from Pfizer, Fisher-Paykel, Gilead, Alexion, Astellas.